Impact of lipid nanoparticle size on mRNA vaccine immunogenicity

Lipid nanoparticles (LNP) are effective delivery vehicles for messenger RNA (mRNA) and have shown promise for vaccine applications. Yet there are no published reports detailing how LNP biophysical properties can impact vaccine performance.

In our hands, a retrospective analysis of mRNA LNP vaccine in vivo studies revealed a relationship between LNP particle size and immunogenicity in mice using LNPs of various compositions. To further investigate this, we designed a series of studies to systematically change LNP particle size without altering lipid composition and evaluated biophysical properties and immunogenicity of the resulting LNPs.

While small diameter LNPs were substantially less immunogenic in mice, all particle sizes tested yielded a robust immune response in non-human primates (NHP).

Read the article here

Article information: Kimberly J. Hassett, Jaclyn Higgins, Angela Woods, Becca Levy, Yan Xia, Chiaowen Joyce Hsiao, Edward Acosta, Örn Almarsson, Melissa J. Moore, Luis A. Brito. Impact of lipid nanoparticle size on mRNA vaccine immunogenicity, Journal of Controlled Release, Volume 335, 2021.

Ingredients and Excipients in the COVID-19 Vaccines

mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability

You might also like